160 related articles for article (PubMed ID: 2300238)
1. T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors.
Hartung HP; Hughes RA; Taylor WA; Heininger K; Reiners K; Toyka KV
Neurology; 1990 Feb; 40(2):215-8. PubMed ID: 2300238
[TBL] [Abstract][Full Text] [Related]
2. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
Hartung HP; Reiners K; Schmidt B; Stoll G; Toyka KV
Ann Neurol; 1991 Jul; 30(1):48-53. PubMed ID: 1929228
[TBL] [Abstract][Full Text] [Related]
3. T lymphocyte activation antigens in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
Taylor WA; Hughes RA
J Neuroimmunol; 1989 Sep; 24(1-2):33-9. PubMed ID: 2808686
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Maimone D; Annunziata P; Simone IL; Livrea P; Guazzi GC
J Neuroimmunol; 1993 Aug; 47(1):55-61. PubMed ID: 8376548
[TBL] [Abstract][Full Text] [Related]
5. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
[TBL] [Abstract][Full Text] [Related]
6. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis.
Vedeler CA; Matre R; Sadallah S; Schifferli J
J Neuroimmunol; 1996 Jun; 67(1):17-20. PubMed ID: 8707926
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barré syndrome.
Bansil S; Mithen FA; Cook SD; Sheffet A; Rohowsky-Kochan C
Neurology; 1991 Aug; 41(8):1302-5. PubMed ID: 1866024
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage.
Hohnoki K; Inoue A; Koh CS
J Neuroimmunol; 1998 Jul; 87(1-2):27-32. PubMed ID: 9670842
[TBL] [Abstract][Full Text] [Related]
9. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
10. [A study of soluble form of selectin family in the sera of patients with neuroimmunological disorders].
Sakai T; Inoue A; Koh CS; Yamazaki M; Yanagisawa N
Rinsho Shinkeigaku; 1998 Mar; 38(3):197-202. PubMed ID: 9711113
[TBL] [Abstract][Full Text] [Related]
11. Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal.
Chalon MP; Sindic CJ; Laterre EC
Acta Neurol Scand; 1993 Feb; 87(2):77-82. PubMed ID: 8442399
[TBL] [Abstract][Full Text] [Related]
12. Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases.
Van den Berg LH; Mollee I; Wokke JH; Logtenberg T
J Neuroimmunol; 1995 Apr; 58(1):37-42. PubMed ID: 7730448
[TBL] [Abstract][Full Text] [Related]
13. [A study of soluble form of L-selectin in blood of patients with neuroimmunological disorders].
Sakai T; Inoue A; Koh CS; Yamazaki M; Yanagisawa N
Arerugi; 1996 Jul; 45(7):672-7. PubMed ID: 8831172
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Ilyas AA; Mithen FA; Dalakas MC; Chen ZW; Cook SD
J Neurol Sci; 1992 Jan; 107(1):111-21. PubMed ID: 1578228
[TBL] [Abstract][Full Text] [Related]
15. Immune-mediated demyelination.
Hartung HP
Ann Neurol; 1993 Jun; 33(6):563-7. PubMed ID: 8498835
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterisation of T lymphocytes from sural nerve biopsies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Ben-Smith A; Gaston JS; Barber PC; Winer JB
J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):362-8. PubMed ID: 8890774
[TBL] [Abstract][Full Text] [Related]
17. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
18. [Detection of interleukin-6 in serum and cerebrospinal fluid of patients with neuroimmunological diseases].
Shimada K; Koh CS; Yanagisawa N
Arerugi; 1993 Aug; 42(8):934-40. PubMed ID: 8250733
[TBL] [Abstract][Full Text] [Related]
19. The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome.
Patzold T; Sindern E; Ossege-Pohle L; Malin JP
J Neurol; 1998 Dec; 245(12):803-8. PubMed ID: 9840353
[TBL] [Abstract][Full Text] [Related]
20. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
Radziwill AJ; Kuntzer T; Steck AJ
Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
